Glover Steve C
SEC-identified person · CIK 1304406 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Oncolytics Biotech INC ONCY | Director | filed 2026 - 2026 |
| PDS Biotechnology Corp PDSB | Director | filed 2019 - 2026 |
| Zyversa Therapeutics, Inc. ZVSA | Director · Chief Executive Officer | filed 2022 - 2025 |
| Ambrx Biopharma, Inc. AMAM | Director | filed 2024 - 2024 |
| Ambrx Biopharma Inc. AMAM | Director | filed 2023 - 2023 |
| Insmed Inc INSM | President Follow-on Biologics | filed 2007 - 2009 |
| Multi Link Telecommunications INC MLNK | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.